About this page

Our systems have detected unusual traffic from your computer network. This page checks to see if it's really you sending the requests, and not a robot. Why did this happen?

IP address: 3.237.65.102
Time: 2024-03-29T01:53:35Z
URL: http://scholar.google.com/scholar_lookup?title=Randomized%2C+open-label+phase+II+study+evaluating+the+efficacy+safety+of+Talimogene+laherparepvec+in+combination+with+ipilimumab+versus+ipilimumab+alone+in+patients+with+advanced%2C+unresectable+melanoma&author=Chesney&journal=J+Clin+Oncol&doi=10.1200%2FJCO.2017.73&pmid=28981385